Table 1.
Comparison of control and intervention clinic characteristics during the baseline and evaluation periods
| Characteristic | Baseline Period (January-February 2018) | Evaluation Period (January-May 2019) | ||||
| Control | Intervention | p-value | Control | Intervention | p-value | |
| Clinicians | 19 | 31 | 20 | 33d | ||
| Total visitsa | 634 | 328 | 943 | 739 | ||
| After hours visits | 15 (2.4%) | 47 (14.3%) | <0.001 | 36 (3.8%) | 243 (32.9%) | <0.001 |
| Visits involving residents | 102 (16.1%) | 56 (17.1%) | 0.765 | 68 (7.2%) | 123 (16.6%) | <0.001 |
| Age (mean years, SD) | 47.1 (16.8) | 51.9 (17.6) | <0.001 | 47.1 (17.5) | 53.4 (19.1) | <0.001 |
| Visits by Females | 446 (70.3%) | 255 (77.7%) | 0.018 | 666 (70.6%) | 568 (76.9%) | 0.005 |
|
Visits with an Antibiotic allergy History |
111 (17.5%) | 95 (29.0%) | <0.001 | 152 (16.1%) | 177 (24.0%) | <0.001 |
| Characteristic | Baseline Period (January-February 2018) | Intervention Period (January-May 2019) | ||||
| Control | Intervention | p-value | Control | Intervention | p-value | |
| Visits by Condition | ||||||
| URIb | 245 (38.6%) | 92 (28.0%) | 287 (30.4%) | 185 (25.0%) | ||
| Acute sinusitis | 91 (14.4%) | 69 (21.0%) | 140 (14.8%) | 133 (18.0%) | ||
| Sore throat | 60 (9.5%) | 27 (8.2%) | 91 (9.7%) | 81 (11.0%) | ||
| Acute bronchitis | 67 (10.6%) | 36 (11.0%) | 126 (13.4%) | 49 (6.6%) | ||
| Acute cystitis | 50 (7.9%) | 43 (13.1%) | 119 (12.6%) | 161 (21.8%) | ||
| Pneumonia | 45 (7.1%) | 34 (10.4%) | 69 (7.3%) | 66 (8.9%) | ||
| Influenza | 46 (7.3%) | 22 (6.7%) | 47 (5.0%) | 15 (2.0%) | ||
| Otherc | 30 (4.7%) | 5 (1.5%) | <0.001 | 64 (6.8%) | 49 (6.6%) | <0.001 |
| Crude Prescribing Rate | 218 (34.4%) | 126 (38.4%) | 373 (39.6%) | 349 (47.2%) | ||
a some patients may have had more than 1 visit bURI –upper respiratory tract infection; c Other includes cough (ICD9 786), other urinary conditions (599); d34 providers completed the education but 1 had no visit data